Docetaxel for the adjuvant treatment of early nodepositive breast cancer: a single technology appraisal

Docetaxel for the adjuvant treatment of early nodepositive breast cancer: a single technology appraisal

Bibliographic Details
Main Authors:	J Chilcott, M Lloyd Jones, A Wilkinson
Format:	Article
Language:	English
Published:	NIHR Journals Library 2009-06-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta13suppl1/02

Similar Items

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

Febrile neutropenia incidence and the variable toxicity profile between brand and generic docetaxel in the adjuvant treatment of breast cancer with docetaxel and cyclophosphamide regimen
by: Flávia Viécili Tarcha, et al.
Published: (2023-12-01)

Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
by: M Lloyd Jones, et al.
Published: (2009-09-01)

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
by: Badiginchala R, et al.
Published: (2023-04-01)

QOL Evaluation of Nab-Paclitaxel and Docetaxel for Early Breast Cancer
by: Hiromi Okuyama, et al.
Published: (2018-10-01)

Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation
by: S Ward, et al.
Published: (2007-10-01)

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
by: Donnez Jacques, et al.
Published: (2008-02-01)

Appraising the quality of meta-analysis for breast cancer treatment in the adjuvant setting: A systematic review
by: Pablo Mandó, et al.
Published: (2021-01-01)

HIV Vif protein in docetaxel treatment of breast cancer cells
by: Pedro Cipriano, et al.
Published: (2021-04-01)

Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study
by: Atul Batra, et al.
Published: (2020-12-01)

Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer
by: Adeel M, et al.
Published: (2019-01-01)

Adjuvant therapy for early breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer
by: Dipika S. Gaikwad, et al.
Published: (2023-05-01)

Adjuvant treatment for breast cancer
by: Flatley, M, et al.
Published: (2019)

Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china
by: Qiaoping Xu, et al.
Published: (2021-02-01)

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group
by: Christoph Thomssen, et al.
Published: (2023-03-01)

Update on Adjuvant Chemotherapy for Early Breast Cancer
by: Murtuza M. Rampurwala, et al.
Published: (2014-10-01)

Update on Adjuvant Chemotherapy for Early Breast Cancer
by: Murtuza M. Rampurwala, et al.
Published: (2014-01-01)

Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer
by: Ling-Cheng Wang MD, et al.
Published: (2020-06-01)

Review of docetaxel in the treatment of gastric cancer
by: Eric D Tetzlaff, et al.
Published: (2008-09-01)

Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatment
by: Alessandro Marco Minisini, et al.
Published: (2011-05-01)

Metformin as an adjuvant in breast cancer treatment
by: Mohsin HK Roshan, et al.
Published: (2019-07-01)

XeNA: Capecitabine Plus Docetaxel, With or Without Trastuzumab, as Preoperative Therapy for Early Breast Cancer
by: Stefan Glück, Edward F. McKenna Jr, Melanie Royce
Published: (2008-01-01)

Mifamurtide for the treatment of osteosarcoma: a single technology appraisal
by: A Pandor, et al.
Published: (2009-10-01)

Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
by: Nadia Harbeck
Published: (2022-03-01)

The Role of Multigene Assays Adjuvant Treatment Decision for Early-Stage Breast Cancer
by: Cornelia NITIPIR, et al.
Published: (2020-06-01)

Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
by: N. Harbeck
Published: (2021-04-01)

High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment
by: Yoshitaka Saito, et al.
Published: (2023-06-01)

Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer
by: Cláudia Vieira, et al.
Published: (2023-01-01)

Current problems in the first-line treatment of metastatic breast cancer: focus on the role of docetaxel
by: Filippo Montemurro
Published: (2010-09-01)

The role of Taxotere in adjuvant therapy for early breast cancer
by: I. V. Kolyadina, et al.
Published: (2014-07-01)

Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review
by: Ochoa Roberto, et al.
Published: (2012-11-01)

Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal
by: S Ward, et al.
Published: (2009-06-01)

Wounding the stroma: Docetaxel's role in dormant breast cancer escape.
by: Tyler T Cooper, et al.
Published: (2023-09-01)

Relationship Between Docetaxel AUC and Neutropenia in Patients with Breast Cancer
by: ZHANG Ni, et al.
Published: (2018-05-01)

Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy
by: Xueyan Zhang, et al.
Published: (2019-09-01)

Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro
by: Mª Jesús Núñez-Iglesias, et al.
Published: (2021-07-01)

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial
by: Giuseppe Gullo, et al.
Published: (2019-07-01)

Effect of Docetaxel on Matrix Metalloproteinase 1 Expression in Freund’s Adjuvant Induced Arthritis
by: Omar Alghulami, et al.
Published: (2024-03-01)